Zenasia Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.50 Cr
as on 17-06-2024
- Paid Up Capital ₹ 4.50 Cr
as on 17-06-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.23 Cr
as on 17-06-2024
- Revenue 102.49%
(FY 2023)
- Profit -46.04%
(FY 2023)
- Ebitda -133.63%
(FY 2023)
- Net Worth -166.29%
(FY 2023)
- Total Assets -0.58%
(FY 2023)
About Zenasia Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 Cr and a paid-up capital of Rs 4.50 Cr.
The company currently has active open charges totaling ₹10.23 Cr.
Vijay Sanampudi, Bhanuprakash Vinta, Narasimha Reddy, and One other member serve as directors at the Company.
- CIN/LLPIN
U02929TG2016PTC112021
- Company No.
112021
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Sangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Zenasia Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhanuprakash Vinta  | Director | 19-Sep-2016 | Current |
| Vijay Sanampudi | Director | 19-Sep-2016 | Current |
| Narasimha Reddy | Director | 15-Mar-2017 | Current |
| Jayaprakash Chinnapureddy | Director | 19-Sep-2016 | Current |
Financial Performance of Zenasia Life Sciences.
Zenasia Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 102.49% increase. The company also saw a substantial fall in profitability, with a 46.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 166.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenasia Life Sciences?
In 2022, Zenasia Life Sciences had a promoter holding of 66.67% and a public holding of 33.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zenasia Healthcare Private LimitedActive 4 years 3 monthsVijay Sanampudi and Bhanuprakash Vinta are mutual person
- Zenasia Infratech Private LimitedActive 5 years 5 months
Vijay Sanampudi and Bhanuprakash Vinta are mutual person
- Westmax Healthcare Private LimitedActive 1 year 11 months
Jayaprakash Chinnapureddy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 17 Nov 2017 | ₹10.23 Cr | Open |
How Many Employees Work at Zenasia Life Sciences?
Unlock and access historical data on people associated with Zenasia Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenasia Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenasia Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
